Long-term use of immunotherapy may be safe for patients with alveolar soft part sarcoma
Reports and Proceedings
Updates every hour. Last Updated: 22-Jun-2026 17:15 ET (22-Jun-2026 21:15 GMT/UTC)
Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily affects adolescents and young adults, who received immunotherapy beyond the standard two years, according to results from a phase II clinical trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2026, held April 17-22.
University of Cincinnati Cancer Center researchers will present abstracts at the American Association for Cancer Research Annual Meeting 2026 April 17 to 22 in San Diego.
New research from USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, suggests that eating fruits, vegetables and whole grains may increase chance of early onset lung cancer.